In vitro screening of compounds for targeting gastric cancer with Y220C p53 mutation: a molecule combining zinc chelation and a Michael acceptor drives CDKN1 and BBC3 expression to restore a p53-dependent cytotoxicity
Journal of Enzyme Inhibition and Medicinal Chemistry · 31.12.2026 · 41 (1)
DOI: 10.1080/14756366.2026.2638836 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Enzyme Inhibition and Medicinal Chemistry, online erschienen am 21.05.2026. Verfasst von Simon Nannini und 20 weiteren Autor:innen. Beteiligte Einrichtung: "Streinth" Laboratory, University of Strasbourg, INSERM UMR_S 1113, Strasbourg, France. Hauptthemen laut MEDLINE: Tumor Suppressor Protein p53, Stomach Neoplasms, Antineoplastic Agents, Zinc. Die Arbeit nennt 65 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Ligue Contre le Cancer, German Research Foundation, Structural Genomics Consortium (SGC.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- "Streinth" Laboratory, University of Strasbourg, INSERM UMR_S 1113, Strasbourg, France.
- "SMART" Laboratory, University of Strasbourg, INSERM UMR_S 1113, Strasbourg, France.
- Sussex Drug Discovery Centre, School of Life Sciences, University of Sussex, Brighton, East Sussex, UK.
- Department of Chemistry, School of Life Sciences, University of Sussex, Brighton, East Sussex, UK.
- EastCHEM School of Chemistry, University of Edinburgh, Joseph Black Building, Edinburgh, UK.
- Department of Inorganic and Analytical Chemistry, University of Debrecen, Debrecen, Hungary.
Förderung
- Ligue Contre le Cancer
- German Research Foundation
- Structural Genomics Consortium (SGC
- European Partnership Development Fellowship
- ITI Innovec
- Itmo Cancer PCSI
Zitieren
APA
Nannini, S., Sieffert, C., McGown, A., Gao, X. Y., Jarvis, A., Kostakis, G. E., Galvacsi, A., Kallay, C., Moraru, R., Baud, M. G., Mandel, S., Balourdas, D. I., Joerger, A. C., Orvain, C., Peschard, S., Nion, A., Mellitzer, G., Lottiaux, S., Spencer, J., …, & Gaiddon, C. (2026). In vitro screening of compounds for targeting gastric cancer with Y220C p53 mutation: a molecule combining zinc chelation and a Michael acceptor drives CDKN1 and BBC3 expression to restore a p53-dependent cytotoxicity. Journal of Enzyme Inhibition and Medicinal Chemistry, 41(1). https://doi.org/10.1080/14756366.2026.2638836
Vancouver
Nannini S, Sieffert C, McGown A, Gao XY, Jarvis A, Kostakis GE, et al. In vitro screening of compounds for targeting gastric cancer with Y220C p53 mutation: a molecule combining zinc chelation and a Michael acceptor drives CDKN1 and BBC3 expression to restore a p53-dependent cytotoxicity. Journal of Enzyme Inhibition and Medicinal Chemistry. 2026;41(1). doi:10.1080/14756366.2026.2638836
BibTeX
@article{Nannini2026,
author = {Nannini, Simon and Sieffert, Céline and McGown, Andrew and Gao, Xin-Yue and Jarvis, Amanda and Kostakis, Georges E and Galvacsi, Antal and Kallay, Csilla and Moraru, Ruxandra and Baud, Matthias G and Mandel, Sebastian and Balourdas, Dimitros-Ilias and Joerger, Andreas C and Orvain, Christophe and Peschard, Simon and Nion, Audrey and Mellitzer, Georg and Lottiaux, Sophie and Spencer, John and Gross, Isabelle and Gaiddon, Christian},
title = {In vitro screening of compounds for targeting gastric cancer with Y220C p53 mutation: a molecule combining zinc chelation and a Michael acceptor drives CDKN1 and BBC3 expression to restore a p53-dependent cytotoxicity},
journal = {Journal of Enzyme Inhibition and Medicinal Chemistry},
year = {2026},
volume = {41},
number = {1},
doi = {10.1080/14756366.2026.2638836}
}
EUVIMED